AngioDynamics Inc expected to post a loss of 13 cents a share - Earnings Preview

AngioDynamics

02/10/2023 13:35

* AngioDynamics Inc  ANGO.OQ   ANGO.O  is expected to show a
fall
in quarterly revenue when it reports  results 
    * The Latham New York-based  company is expected to report 
a
4.7% decrease in revenue to $77.693 million from $81.54 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for AngioDynamics Inc
is for
a loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $19​, above​ its last closing price of $7.31. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 May. 31 2023  0.03        0.02       0.02      Met     -11.1
 Feb. 28 2023  -0.01       -0.01      -0.03     Missed  -300
 Nov. 30 2022  -0.01       -0.01      0.01      Beat    200​
 Aug. 31 2022  -0.02       -0.02      -0.06     Missed  -166.7
 ​​May.        0.01        0.01       0.01      Met     33.3
 31 2022                                                
 Feb. 28 2022  -0.01       -0.01      0.03      Beat    340​
 Nov. 30 2021  0.00        0.01       -0.02     Missed  -481
 Aug. 31 2021  -0.04       -0.04      -0.02     Beat    55.6
 This summary was machine generated October 2 at 12:35 GMT.  All
figures in US dollars  unless otherwise stated